An international acquirer targeting a Chinese business often discovers that the transaction structure it used successfully in Europe or the Gulf bears little resemblance to what Chinese commercial legislation and regulators will accept. Approval chains are longer, disclosure obligations differ sharply from common law norms, and a misstep in the regulatory sequence can terminate a deal that has already consumed months of negotiation.
M&A transactions in China require foreign acquirers to satisfy a layered set of approvals under Chinese corporate legislation, competition law. Additionally. Foreign investment rules administered by the State Administration for Market Regulation (SAMR) and the National Development and Reform Commission. The core transaction documents – including a share purchase agreement (SPA) and, where applicable, joint venture contracts – must align with mandatory local-law requirements that override foreign governing law clauses in many situations. From initial due diligence to final regulatory clearance, a mid-market cross-border acquisition typically takes between six and eighteen months to complete.
This page covers the legal instruments, approval procedures, common pitfalls, cross-border considerations involving the UAE and EU. Additionally. A self-assessment checklist to help international clients determine whether and how to proceed with M&A activity in China.
The regulatory setting for inbound M&A in China
China's body of foreign investment legislation has undergone substantial reform in recent years. The Foreign Investment Law and its accompanying regulations have consolidated the approval architecture, but significant sector-specific restrictions remain under the "negative list" system administered jointly by central and local authorities. Transactions touching sectors on the negative list – which includes financial services, media, telecommunications, and certain technology categories – require approvals beyond those needed for general commercial acquisitions.
The primary regulatory body for merger control is Guowuyuan (the State Council), acting through SAMR. Merger filings before SAMR are mandatory when the combined turnover of the parties exceeds prescribed thresholds in China or globally. Failing to file – or closing before clearance is granted – carries significant consequences. SAMR has the power to unwind a completed transaction, impose fines, and require structural remedies. International clients accustomed to European or US merger control timelines should note that the Chinese review process has its own pacing and is not directly comparable.
Beyond merger control, inbound acquisitions of Chinese companies must navigate the Ministry of Commerce (MOFCOM) approval process for certain restricted and encouraged sectors. The National Development and Reform Commission (NDRC) plays a parallel role when the transaction involves significant outbound investment by Chinese parties or concerns strategic industries. Both agencies operate within statutory deadlines, but practitioners consistently observe that pre-filing engagement and informal consultations with officials materially affect how those deadlines run in practice.
A non-obvious risk at this stage is the interaction between national security review and merger control. China operates a dedicated national security review mechanism for foreign acquisitions in sensitive sectors. This review is separate from SAMR merger control and can be triggered at any point before or after a filing. Unlike merger control, national security review has no fixed statutory deadline, which creates genuine deal certainty risk for acquirers in technology, infrastructure, and defence-adjacent sectors.
Companies already holding a presence in China through a Wholly Foreign-Owned Enterprise (WFOE) may have different procedural paths available to them compared with first-time entrants. For a broader account of the corporate structures available to foreign investors, the firm's analysis of corporate law in China sets out the formation and governance options in detail.
Key instruments and procedures in a China M&A transaction
The transaction documentation in a Chinese M&A deal must satisfy both the commercial expectations of the parties and the formal requirements imposed by Chinese corporate legislation and regulatory bodies. The gap between what a foreign acquirer considers standard and what Chinese law mandates is a recurring source of delay and, in some cases, transaction failure.
Share transfers and asset purchases. Foreign acquirers may acquire a Chinese target either by purchasing equity interests in the target company or by acquiring its assets directly. Each route carries distinct tax, liability, and approval consequences. An equity acquisition of a limited liability company (LLC). the most common target vehicle. requires the transfer to be recorded in the company's shareholder register and the business registration updated with the local Administration for Market Regulation. A notarised or authenticated gongzheng (notarised instrument) may be required depending on the target's corporate structure and the governing provincial rules.
The share purchase agreement. The SPA in a China-context transaction serves both as the commercial record of the deal and as one of the documents submitted to the regulatory authorities. Representations and warranties in a Chinese SPA tend to be narrower in scope than in English law SPAs. Chinese courts and arbitral bodies do not readily accept extensive warranty schedules that go beyond what Chinese commercial legislation recognises as actionable. Sellers regularly resist warranty and indemnity provisions that have no direct equivalent in Chinese law. Practitioners experienced in China deals structure representations and warranties around the categories that Chinese arbitral bodies will enforce. Additionally. Then address residual risk through price adjustment mechanisms, escrow arrangements. Alternatively, warranty and indemnity insurance placed in a third jurisdiction.
Closing conditions. The closing conditions in a Chinese M&A transaction almost always include SAMR merger clearance (if thresholds are met). MOFCOM approval for restricted sectors, NDRC filing, foreign exchange registration with the State Administration of Foreign Exchange (SAFE), and business registration update. Each of these steps runs sequentially or in parallel depending on the applicable rules. A common mistake by foreign clients is to set a fixed long-stop date in the SPA without building in adequate extensions for each regulatory approval. When one approval is delayed, the fixed long-stop triggers termination rights before the deal has a real chance to close.
Due diligence in China. Due diligence in a Chinese target company presents specific challenges. Publicly available corporate registry information is less comprehensive than in common law jurisdictions. Land use rights – which are the closest Chinese equivalent to freehold ownership – are registered in a separate system and require specialist verification. Employment liabilities, social insurance arrears, and undisclosed related-party transactions are among the most frequently encountered issues in pre-signing due diligence. Tax compliance gaps are another significant source of post-closing disputes, particularly where the target has operated across multiple Chinese provinces. An experienced China M&A practitioner will use a combination of official registry searches, on-the-ground operational reviews, and specialist financial due diligence to build an accurate picture of the target.
To receive an expert assessment of your M&A strategy in China, contact us at info@ferrazwhitmore.com.
Practical pitfalls for international acquirers
Several recurring patterns distinguish successful China M&A transactions from those that stall or collapse. Understanding them before entering negotiations is considerably less costly than encountering them mid-process.
Assuming the SPA governs everything. Chinese corporate legislation imposes obligations on shareholders and boards that cannot be contractually waived between the parties. Board approval thresholds, minority shareholder rights, and pre-emption provisions embedded in Chinese company law continue to apply even when the SPA purports to override them. A foreign acquirer that relies exclusively on the SPA without reviewing the target's articles of association and the statutory baseline will face unexpected procedural blocks.
Overlooking the foreign exchange approval step. SAFE registration is a separate requirement from SAMR clearance and business registration. Without it, the acquisition price cannot be remitted to the seller in foreign currency. Deals have been fully approved by all other regulators only to stall at the SAFE stage because the documentation submitted did not match the final transaction structure. Ensuring SAFE-compliant transaction documentation from the outset – rather than retrofitting it after the SPA is signed – is a practical measure that experienced practitioners implement early in the process.
Underestimating the role of the seller's government relationships. In state-owned enterprise (SOE) acquisitions. The approval chain extends beyond regulatory filings to internal party and administrative approvals that have no formal statutory basis but materially affect timeline. Foreign acquirers who treat SOE transactions as purely commercial deals and ignore this dimension frequently encounter unexplained delays at the final stages of an otherwise complete regulatory process.
Dispute resolution clause selection. Many international acquirers instinctively choose a foreign arbitral seat – London, Singapore, or Hong Kong – for their China M&A disputes. This is often commercially sensible. However, there is a nuanced point: a foreign arbitral award must be enforced against assets held in China. Additionally. Chinese courts apply the New York Convention framework in a manner that differs in some procedural respects from other signatory states. Where the primary assets are in China and the seller is a Chinese entity. Practitioners often consider including CIETAC (China International Economic and Trade Arbitration Commission) arbitration or a hybrid clause that addresses both the commercial dispute and the enforcement step in a coordinated way. For clients who have experience with parallel M&A activity in the Gulf, the firm's coverage of M&A transactions in the UAE illustrates how similar enforcement considerations arise in that jurisdiction.
Integration planning in a restricted-data environment. Post-closing integration of a Chinese target involves data localisation rules that restrict the cross-border transfer of personal data and certain categories of business data. An acquirer that plans to integrate Chinese operations into a global IT architecture without first obtaining the required data transfer assessments and government approvals risks significant regulatory exposure. This is a post-signing issue that should be addressed in the due diligence and closing conditions phases, not after the keys have been handed over.
Cross-border considerations: UAE, EU, and multi-jurisdictional deals
M&A transactions involving Chinese targets frequently have a multi-jurisdictional dimension. The acquirer may be a UAE holding company, a European strategic buyer, or an institutional investor operating through a Cayman or Luxembourg vehicle. Each structure introduces its own regulatory and tax considerations at the interface with Chinese law.
UAE-headquartered acquirers. UAE entities acquiring Chinese businesses must consider that China does not treat all foreign investors identically. The bilateral investment treaty position between China and the UAE, while developing, does not yet offer the same level of substantive protection available under some European investment treaty regimes. UAE acquirers operating through DIFC or ADGM vehicles should verify how the proposed transaction structure is characterised under Chinese foreign investment rules. As the "look-through" approach applied by some Chinese regulators can reclassify the ultimate beneficial owner's nationality with material consequences for applicable approvals.
EU-based acquirers and outbound investment screening. The EU Foreign Subsidies Regulation and national-level foreign direct investment screening mechanisms in Germany, France, Italy. Additionally. Other EU member states have expanded their scope to cover situations where a European acquirer of a Chinese business is itself a recipient of foreign state subsidies or where Chinese state capital flows through the European buyer's shareholder structure. This means that a transaction structured in China may also trigger a European regulatory review. EU-based acquirers should conduct a dual-track regulatory assessment covering both Chinese inbound approvals and European outbound or domestic screening obligations.
Holding structure selection. The choice of intermediate holding structure. Hong Kong, Singapore, Cayman Islands. Alternatively. A European jurisdiction. affects withholding tax on dividends, capital gains treatment on a future exit. Additionally, the availability of bilateral investment treaty protections. Chinese tax legislation applies a beneficial ownership test to dividend and interest payments flowing to foreign holding companies, and the test is applied with increasing rigour. Shell holding companies with no genuine economic substance are at real risk of being denied treaty benefits, which materially affects the economics of the investment over its lifecycle. A detailed overview of formation and holding structure options is available in the firm's guide to company formation in China.
Financing the acquisition. Cross-border debt financing of a Chinese acquisition is subject to foreign debt registration requirements and macro-prudential controls that limit the total foreign debt an onshore Chinese entity can carry. Private equity sponsors and strategic acquirers using leveraged structures should model their financing plans against these constraints before committing to acquisition financing terms that may not be deployable onshore.
For a tailored strategy on cross-border M&A transactions in China, reach out to info@ferrazwhitmore.com.
Self-assessment checklist before initiating a China M&A transaction
An M&A transaction in China is appropriate if the following conditions are met. Use this checklist as a preliminary filter before committing resources to the formal process.
- The target sector is not on the negative list for foreign investment, or the acquirer has identified a viable structure for restricted sectors (joint venture, variable interest entity, or minority stake).
- The acquirer's turnover thresholds have been assessed against SAMR merger control filing requirements, and external competition counsel has confirmed the likely timeline for any required filing.
- A Chinese-law qualified practitioner has reviewed the target's corporate documents, shareholder register, and land use rights to identify pre-emptive rights or transfer restrictions that require waiver or approval.
- The SPA representations and warranties have been reviewed against Chinese commercial legislation to confirm which provisions are enforceable in Chinese courts or under CIETAC arbitration rules.
- SAFE registration requirements have been mapped against the proposed transaction structure and settlement currency.
- National security review exposure has been assessed based on the target's sector, data holdings, and any government contracts.
- The post-closing data transfer and integration plan has been reviewed against Chinese data protection legislation.
- The holding structure has been stress-tested for Chinese beneficial ownership and anti-avoidance rules applicable to dividend repatriation and exit gains.
If any of these items cannot be confirmed prior to signing, the transaction carries elevated regulatory and legal risk that should be addressed before proceeding.
Frequently asked questions
- How long does a typical inbound M&A transaction in China take from signing to closing?
- A mid-market acquisition of a non-restricted Chinese business typically closes between four and nine months after signing, assuming all regulatory filings are made promptly. Transactions in restricted sectors, those requiring SAMR merger control review, or those with national security review exposure can extend to twelve to eighteen months or longer. Building realistic regulatory approval timelines into the SPA's closing conditions and long-stop date is essential to avoid unintended termination rights.
- Can the SPA in a China M&A deal be governed by English law or another foreign law?
- Parties can choose a foreign governing law for commercial provisions of the SPA. In practice, however, Chinese corporate legislation governs the mechanics of the equity transfer, the validity of shareholder approvals, and the registration process regardless of the contractual choice of law. Many practitioners use a split governing law approach: the commercial warranty and indemnity provisions are governed by English or Hong Kong law. While the equity transfer deed and ancillary corporate documents are governed by Chinese law to satisfy registration requirements and regulatory submissions.
- Is warranty and indemnity insurance available for China M&A transactions, and is it commonly used?
- Warranty and indemnity (W&I) insurance is available for Chinese M&A transactions, though the market is more limited than for European or US deals. Insurers typically apply broader exclusions for China-specific risks, including tax compliance gaps, environmental liabilities, and regulatory non-compliance that was known or discoverable with reasonable due diligence. Engaging a law firm in China with specialist W&I experience. and conducting thorough due diligence before approaching the insurance market – materially improves the scope of coverage available and reduces the exclusions that underwriters impose.
About Ferraz & Whitmore
Ferraz & Whitmore is an international law firm based in Lisbon, advising business clients across 46 jurisdictions. Our team combines Portuguese civil law expertise with English common law tradition to deliver cross-border legal solutions in M&A transactions in China and across the Asia-Pacific region. We advise international entrepreneurs, institutional investors, and in-house legal teams on the full transaction lifecycle – from due diligence and SPA negotiation through regulatory approvals and post-closing integration. As an international law firm in China-related matters, Ferraz &. Whitmore brings direct experience of the intersection between Chinese corporate legislation and common law deal mechanics. Allowing clients to structure transactions that are both commercially robust and regulatorily sound. Our M&A practice covers transactions in civil law and common law systems across more than 15 practice areas, supported by a network of local counsel in China and key regional hubs. Practitioners on our team have advised on acquisitions involving SAMR merger control filings, national security review procedures, and CIETAC dispute resolution. To discuss how our M&A practice can support your transaction in China, contact us at info@ferrazwhitmore.com.
Disclaimer: This publication is provided for informational purposes only and does not constitute legal advice. The information herein should not be relied upon as a substitute for professional legal counsel tailored to your specific circumstances. Ferraz & Whitmore assumes no liability for actions taken or not taken based on the contents of this material. For advice regarding your particular situation, please contact info@ferrazwhitmore.com.